First Time Loading...

Uscom Ltd
ASX:UCM

Watchlist Manager
Uscom Ltd Logo
Uscom Ltd
ASX:UCM
Watchlist
Price: 0.027 AUD 3.85% Market Closed
Updated: May 4, 2024

Uscom Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Uscom Ltd
Revenue Peer Comparison

Comparables:
NTI
IPD
C
CYC
COH
EMV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Uscom Ltd
ASX:UCM
Revenue
AU$2.7m
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Neurotech International Ltd
ASX:NTI
Revenue
AU$1.3m
CAGR 3-Years
148%
CAGR 5-Years
83%
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
Revenue
AU$10.5m
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
13%
C
Cyclopharm Ltd
ASX:CYC
Revenue
AU$27.8m
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
9%
Cochlear Ltd
ASX:COH
Revenue
AU$2.1B
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
11%
EMvision Medical Devices Ltd
ASX:EMV
Revenue
AU$7.1m
CAGR 3-Years
93%
CAGR 5-Years
70%
CAGR 10-Years
N/A

See Also

What is Uscom Ltd's Revenue?
Revenue
2.7m AUD

Based on the financial report for Jun 30, 2023, Uscom Ltd's Revenue amounts to 2.7m AUD.

What is Uscom Ltd's Revenue growth rate?
Revenue CAGR 5Y
-1%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Uscom Ltd have been -12% over the past three years , -1% over the past five years .